56 related articles for article (PubMed ID: 31543246)
1. Assessing pathogenic mutations in dental follicles as an attempt to identify early events in odontogenic tumours tumourigenesis.
Coura BP; de Resende TAC; de Menezes VCB; Bernardes VF; de Sousa SF; Diniz MG; Gomez RS; Gomes CC
Arch Oral Biol; 2020 May; 113():104523. PubMed ID: 31543246
[TBL] [Abstract][Full Text] [Related]
2. Adenoid Ameloblastoma with BRAF p.V600E Mutation Revealing Ameloblastomatous Origin: A First Case Report.
Noda Y; Sawada S; Sakagami T; Kojima Y; Higasa K; Tsuta K
Head Neck Pathol; 2023 Sep; 17(3):788-792. PubMed ID: 37093491
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of BRAF p.V600E and Detection Methods in Benign Mixed and Malignant Odontogenic Tumors: A Systematic Review.
Severino-Lazo RJG; de Vasconcelos Carvalho M; Campello CP; Moraes SLD; do Egito Vasconcelos BC; Pellizzer EP
Head Neck Pathol; 2023 Dec; 17(4):1000-1010. PubMed ID: 38057461
[TBL] [Abstract][Full Text] [Related]
4. [BRAF V600E expression in ameloblastomas, ameloblastic carcinomas and cysts].
Pei J; Zhang L; Jia YX; Chen WH
Shanghai Kou Qiang Yi Xue; 2023 Dec; 32(6):630-634. PubMed ID: 38494972
[TBL] [Abstract][Full Text] [Related]
5. Association of MDM2 Overexpression in Ameloblastomas with
Tosios KI; Kalogirou EM; Koutlas IG
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396916
[TBL] [Abstract][Full Text] [Related]
6. New Ameloblastoma Cell Lines Enable Preclinical Study of Targeted Therapies.
Nguyen J; Saffari PS; Pollack AS; Vennam S; Gong X; West RB; Pollack JR
J Dent Res; 2022 Nov; 101(12):1517-1525. PubMed ID: 35689405
[TBL] [Abstract][Full Text] [Related]
7. Role of podoplanin expression in deciding the invasive potential of ameloblastoma - A retrospective IHC study.
Ganvir SM; Khobragade PG; Bamane SA; Kumavat R; Dalmia A
J Oral Biol Craniofac Res; 2016; 6(3):187-193. PubMed ID: 27761382
[TBL] [Abstract][Full Text] [Related]
8. Metastasising ameloblastoma or ameloblastic carcinoma? A case report with mutation analyses.
Hurník P; Putnová BM; Ševčíková T; Hrubá E; Putnová I; Škarda J; Havel M; Res O; Cvek J; Buchtová M; Štembírek J
BMC Oral Health; 2023 Aug; 23(1):563. PubMed ID: 37573343
[TBL] [Abstract][Full Text] [Related]
9. Adenoid 'ameloblastoma': Clinicopathological description of 4 additional BRAF-negative cases.
Khalaj F; Cinel L; Aminishakib P; Mosavat F; Soluk-Tekkesin M
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101585. PubMed ID: 37543210
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of ameloblastoma.
Marín-Márquez C; Kirby J; Hunter KD
J Oral Pathol Med; 2024 May; 53(5):277-293. PubMed ID: 38664938
[TBL] [Abstract][Full Text] [Related]
11. BRAF V600E mutation detected in cell-free DNA from conventional ameloblastomas fluid aspirate.
Martins-de-Barros AV; Barros AMI; Lazo RJGS; Barbosa Neto AG; Araújo FADC; Carvalho MV
Oral Dis; 2024 Jan; ():. PubMed ID: 38168084
[No Abstract] [Full Text] [Related]
12. Targeted therapies in ameloblastomas and amelobastic carcinoma-A systematic review.
Bologna-Molina R; Schuch L; Magliocca K; van Heerden W; Robinson L; Bilodeau EA; Hussaini HM; Soluk-Tekkesin M; Adisa AO; Tilakaratne WM; Li J; Gomez RS; Hunter KD
Oral Dis; 2024 May; ():. PubMed ID: 38693620
[TBL] [Abstract][Full Text] [Related]
13. Targeted Next-Generation Sequencing and Allele-Specific Quantitative PCR of Laser Capture Microdissected Samples Uncover Molecular Differences in Mixed Odontogenic Tumors.
Coura BP; Bernardes VF; de Sousa SF; Diniz MG; Moreira RG; de Andrade BAB; Romañach MJ; Pontes HAR; Gomez RS; Odell EW; Gomes CC
J Mol Diagn; 2020 Dec; 22(12):1393-1399. PubMed ID: 32966885
[TBL] [Abstract][Full Text] [Related]
14. Ameloblastoma shows nuclear BAP1 immunoexpression, independently of the BRAF V600E status.
Santana LADM; Santana EMR; Albuquerque-Júnior RLC; Takeshita WM; Braga Pereira N; Gomez RS; Gomes CC; de Sousa SF
Oral Dis; 2021 Jul; 27(5):1238-1242. PubMed ID: 32945606
[No Abstract] [Full Text] [Related]
15. Whole Exome Sequencing of
Shimura M; Nakashiro KI; Sawatani Y; Hasegawa T; Kamimura R; Izumi S; Komiyama Y; Fukumoto C; Yagisawa S; Yaguchi E; Hitomi-Koide M; Hyodo T; Uchida D; Kawamata H
In Vivo; 2020; 34(6):3233-3240. PubMed ID: 33144428
[TBL] [Abstract][Full Text] [Related]
16. The BRAF p.V600E mutation is a common event in ameloblastomas but is absent in odontogenic keratocysts.
Zhang R; Yang Q; Qu J; Hong Y; Liu P; Li T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):229-235. PubMed ID: 31987674
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel molecular characteristics and cellular biological properties in ameloblastoma.
Kondo S; Ota A; Ono T; Karnan S; Wahiduzzaman M; Hyodo T; Lutfur Rahman M; Ito K; Furuhashi A; Hayashi T; Konishi H; Tsuzuki S; Hosokawa Y; Kazaoka Y
Cancer Med; 2020 Apr; 9(8):2904-2917. PubMed ID: 32096304
[TBL] [Abstract][Full Text] [Related]
18. High frequency of BRAF V600E mutation in Iranian population ameloblastomas.
Derakhshan S; Aminishakib P; Karimi A; Saffar H; Abdollahi A; Mohammadpour H; Kharazi Fard MJ; Memarha A
Med Oral Patol Oral Cir Bucal; 2020 Jul; 25(4):e502-e507. PubMed ID: 32388526
[TBL] [Abstract][Full Text] [Related]
19.
Mamat Yusof MN; Ch'ng ES; Radhiah Abdul Rahman N
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428683
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
